Article Versions Notes

Huebner H, Häberle L, Müller V, Schrader I, Lorenz R, Forstbauer H, Fink V, Schochter F, Bekes I, Mahner S, et al. MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients. Cancers. 2022; 14(7):1721. https://doi.org/10.3390/cancers14071721

Huebner, Hanna, Lothar Häberle, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Visnja Fink, Fabienne Schochter, Inga Bekes, Sven Mahner, and et al. 2022. "MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients" Cancers 14, no. 7: 1721. https://doi.org/10.3390/cancers14071721

Huebner, H., Häberle, L., Müller, V., Schrader, I., Lorenz, R., Forstbauer, H., Fink, V., Schochter, F., Bekes, I., Mahner, S., Jückstock, J., Nabieva, N., Schneeweiss, A., Tesch, H., Brucker, S. Y., Blohmer, J.-U., Fehm, T. N., Heinrich, G., Rezai, M., ... Rack, B. (2022). MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients. Cancers, 14(7), 1721. https://doi.org/10.3390/cancers14071721